GlassScriptPhysician profile
Gabriel S Niles
NPI 1285611699
$3,618.28
in general payments reported to CMS, 2019-2025
35 companies · $756 in 2025
The $756 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $194 · 2021: $323 · 2022: $578 · 2023: $503 · 2024: $791 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $632.55 | 2019-2025 | |
| Lilly USA, LLC | $417.69 | 2019-2025 | Mounjaro, Zepbound, Lyumjev |
| Bayer Healthcare Pharmaceuticals INC. | $379.71 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.21 | 2019-2024 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $319.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $162.87 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $160.97 | 2019-2025 | |
| Glaxosmithkline, LLC. | $128.36 | 2021-2025 | Shingrix, Arexvy |
| Organon LLC | $123.66 | 2022-2023 | Nexplanon |
| Ibsa Pharma INC. | $112.55 | 2022-2024 | Tirosint, Licart, Licart |
| Gilead Sciences, INC. | $91.97 | 2022-2024 | |
| Amgen INC. | $80.06 | 2022-2024 | Prolia, Evenity, Otezla |
| Pfizer INC. | $61.06 | 2022-2025 | |
| Mannkind Corporation | $53.78 | 2019-2020 | |
| Madrigal Pharmaceuticals | $45.78 | 2025 | Rezdiffra |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Niles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.